Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Bactrim Dosing in Hemodialysis Patients

Dosing Guidelines

  • The Centers for Disease Control and Prevention, as reported by MMWR Recommendations and Reports, recommends that for patients on hemodialysis, the dose of Bactrim should be half the standard dose, administered after each dialysis session 1
  • For hemodialysis patients taking standard-strength tablets (400mg-80mg), the recommended dose is 1 tablet after each dialysis session, as suggested by MMWR Recommendations and Reports 1
  • For hemodialysis patients taking double-strength tablets (800mg-160mg), the recommended dose is ½ tablet after each dialysis session, according to MMWR Recommendations and Reports 1

Clinical Applications

  • When used for treatment of active infections in hemodialysis patients, Bactrim should be administered at adjusted doses, ensuring adequate dosing while maintaining the post-dialysis administration schedule, as recommended by MMWR Recommendations and Reports 1

Practical Implementation

  • The MMWR Recommendations and Reports suggest that Bactrim should be administered after the completion of each dialysis session, to minimize toxicity risk and ensure optimal therapeutic outcomes in hemodialysis patients 1

Bactrim Dosing for UTI in Dialysis Patients

Dosing Algorithm for Dialysis Patients

  • The American Family Physician recommends administering one double-strength Bactrim tablet (160mg TMP/800mg SMZ) after each dialysis session, three times weekly, for patients on hemodialysis with a UTI 2

Critical Safety Considerations

  • The American Family Physician suggests that dialysis-specific guidelines supersede standard renal dosing charts, which apply to non-dialysis CKD patients, and recommends a specific three-times-weekly post-dialysis regimen for dialysis patients 2

Bactrim Dosing Considerations in Dialysis Patients

Patient Monitoring and Safety

  • The Centers for Disease Control and Prevention recommends maintaining adequate fluid intake to prevent crystalluria in dialysis patients, although this is less concerning in anuric dialysis patients 3
  • The Centers for Disease Control and Prevention suggests watching for potential drug interactions with anticoagulants, antidiabetic agents, and other medications metabolized hepatically in dialysis patients 3